Loading…

Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide‐ and lenalidomide‐containing regimens

Saved in:

Bibliographic Details
Published in:	British journal of haematology 2019-04, Vol.185 (1), p.142-144
Main Authors:	Storrar, Neill P. F., Mathur, Abhinav, Johnson, Peter R. E., Roddie, P. Huw
Format:	Article
Language:	English
Subjects:	Adult Aged Aged, 80 and over anticoagulants Anticoagulants - adverse effects Anticoagulants - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use direct oral anticoagulants Disease-Free Survival Female Hematology Hemorrhage - chemically induced Humans immunomodulatory drugs Immunotherapy Incidence Lenalidomide - administration & dosage Lenalidomide - adverse effects Male Middle Aged multiple myeloma Multiple Myeloma - blood Multiple Myeloma - drug therapy Myeloma Pyrazoles - adverse effects Pyrazoles - therapeutic use Pyridones - adverse effects Pyridones - therapeutic use Targeted cancer therapy Thalidomide Thalidomide - administration & dosage Thalidomide - adverse effects Thromboembolism - epidemiology Thromboembolism - etiology Thromboembolism - prevention & control Thrombophilia - drug therapy Thrombophilia - etiology thrombosis
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!